Share “Oklahoma City biotech startup seeks...”

Oklahoma City biotech startup seeks funding for clinical trials

Oklahoma City’s EpimedX trying to develop treatment for sickle cell disease, which affects more than 90,000 people in the United States.

BY BRIANNA BAILEY Published: January 10, 2013

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the United States.

“Sickle cell disease...
Read the rest of the story on


  1. 1
    Tulsa-based Williams Cos. outlines policy for possible layoffs
  2. 2
    Vinita letter carrier saves girl from burning building, gets award
  3. 3
    Emails from Gov. Fallin's office show state agencies' struggle to respond to scrutiny over execution
  4. 4
    Planned anti-Muslim protests fizzle in Oklahoma, elsewhere
  5. 5
    Fuel tank explodes in fire at Owasso rock quarry; three firefighters hurt
+ show more


× Trending news Article